+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Pharmacokinetic Drug-Drug Interactions Between Immunosuppressant and Anti-Infective Agents: Antimetabolites and Corticosteroids



Pharmacokinetic Drug-Drug Interactions Between Immunosuppressant and Anti-Infective Agents: Antimetabolites and Corticosteroids



Annals of Transplantation 23: 66-74



Infections account for 15-20% of deaths in transplant recipients, requiring rapid and appropriate therapeutic interventions. Many anti-infective agents interact with immunosuppressive regimens used in transplantation, placing patients at increased risk for adverse drug reactions and prolonged hospitalizations. There is established data regarding the level of evidence and magnitude of interactions between calcineurin inhibitors and mammalian target of rapamycin inhibitors with anti-infective agents. Less is known about the interactions with anti-proliferative agents and corticosteroids, with gaps in knowledge on the appropriate management of these interactions. The objective of this review was to highlight the pharmacokinetic drug-drug interactions between antimetabolites and corticosteroids with commonly used anti-infective agents.

(PDF emailed within 1 workday: $29.90)

Accession: 065402138

Download citation: RISBibTeXText

PMID: 29358572


Related references

Pharmacokinetic drug-drug interactions between calcineurin inhibitors and proliferation signal inhibitors with anti-microbial agents: implications for therapeutic drug monitoring. Journal of Heart and Lung Transplantation 30(2): 124-135, 2011

Prediction of pharmacokinetic drug/drug interactions from In vitro data: interactions of the nonsteroidal anti-inflammatory drug lornoxicam with oral anticoagulants. Drug Metabolism and Disposition: the Biological Fate of Chemicals 28(2): 161-168, 2000

Evaluation of pharmacokinetic drug-drug-interactions. Critical considerations of the relevance of pharmacokinetic drug-drug interactions of proton pump inhibitors in self medication. Medizinische Monatsschrift für Pharmazeuten 34(8): 270-278, 2011

Immunosuppressive drug interactions with anti-infective agents. American Journal of Transplantation 4 Suppl 10: 164-166, 2004

Drug-drug interactions of anti-infective drugs: utility of fluorescence cyp inhibition assays in drug discovery. Drug Metabolism and Drug Interactions 21(3-4): 163-185, 2006

Drug-drug and food-drug pharmacokinetic interactions with new insulinotropic agents repaglinide and nateglinide. Clinical Pharmacokinetics 46(2): 93-108, 2007

Drug interactions involving combination antiretroviral therapy and other anti-infective agents: repercussions for resource-limited countries. Journal of Infectious Diseases 198(7): 948-961, 2008

Drug interactions part 3 classes of drugs and their interactions anti infective agents part 2. Drug Intelligence 3(5): 131-137, 1969

Anti-infective agents, biologics, and vaccines approved by the U.S. Food and Drug Administration's Center for Drug Evaluation and Research in 1993. Antimicrobial Agents and ChemoTherapy 38(4): 908-908, 1994

Undesirable pharmacokinetic drug-to-drug interactions affecting the effectiveness and safety of anti-infectious pharmacotherapy. Polski Merkuriusz Lekarski 42(248): 61-64, 2017

The Anti-Influenza Drug Oseltamivir Exhibits Low Potential to Induce Pharmacokinetic Drug Interactions via Renal Secretion---Correlation of in Vivo and in Vitro Studies. Drug Metabolism and Disposition 30(1): 13-19, 2002

The anti-influenza drug oseltamivir exhibits low potential to induce pharmacokinetic drug interactions via renal secretion-correlation of in vivo and in vitro studies. Drug Metabolism and Disposition: the Biological Fate of Chemicals 30(1): 13-19, 2001

Utilizing In Vitro Dissolution-Permeation Chamber for the Quantitative Prediction of pH-Dependent Drug-Drug Interactions with Acid-Reducing Agents: a Comparison with Physiologically Based Pharmacokinetic Modeling. Aaps Journal 18(6): 1512-1523, 2016

Pharmacokinetic Drug-Drug Interactions Between Vonoprazan and Low-Dose Aspirin or Nonsteroidal Anti-inflammatory Drugs: A Phase 2, Open-Label, Study in Healthy Japanese Men. Clinical Drug Investigation 37(1): 39-49, 2016

Potential drug-drug interactions between anti-cancer agents and community pharmacy dispensed drugs. Pharmacy World and Science 32(5): 575-580, 2011